Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Net Income

Adverum Biotechnlgs Net Income Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Net Income from 2013 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Adverum Biotechnlgs Net Income for the quarter ending June 06, 2020 was $-29m a 44.80% decrease of -13m year over year
  • Adverum Biotechnlgs Net Income for the last 12 months ending June 06, 2020 was $-87m a 29.75% decrease of -26m year over year
  • Adverum Biotechnlgs Annual Net Income for 2019 was $-64m a -12.62% increase of 8m from 2018
  • Adverum Biotechnlgs Annual Net Income for 2018 was $-73m a 22.69% decrease of -16m from 2017
  • Adverum Biotechnlgs Annual Net Income for 2017 was $-56m a -102.59% increase of 58m from 2016
Other Income Statement Metrics:
  • Adverum Biotechnlgs EBITDA for the quarter ending December 12, 2018 was $-21m a 18.17% decrease of -4m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Net Income Data

06/2020$-29m
03/2020$-23m
12/2019$-19m
09/2019$-16m
06/2019$-15m
03/2019$-14m
12/2018$-16m
09/2018$-21m
06/2018$-19m
03/2018$-17m

Annual ADVM Net Income Data

2019$-64m
2018$-73m
2017$-56m
2016$-114m
2015$-47m
2014$-25m
2013$-5m
2012$-2m